Re: Checklist / F&A costs Robert Miller 18 Aug 2005 14:05 EST
This is not a modular budget.......it is a detailed multiproject U54 center grant. Robert Gregory Miller Charles R. Drew University of Medicine and Science Div. of Endocrinology, Metabolism and Molecular Science Administrative Director/Research Administrator xxxxxx@cdrewu.edu Office: 323.563.5961 Fax: 323.563.5966 Notice of Confidentiality This message contains information that may be confidential or privileged. It is intended for the exclusive use of the addressee or any person entitled to receive it. If you received this message in error, please inform the author as soon as possible, do not disclose its contents and delete it from your system -----Original Message----- From: Research Administration List [mailto:xxxxxx@HRINET.ORG] On Behalf Of Manuela Dokie Sent: Thursday, August 18, 2005 11:42 AM To: xxxxxx@HRINET.ORG Subject: Re: [RESADM-L] Checklist / F&A costs Hi: If this is NIH format, the separated F&A is not detailed on the checklist because on the checklist the consortium/contractual F&A costs become part of the requester's direct costs. However, the budget forms (Form Pages 4 and , and the Modular Format) require you list the Consortium/Contractual F&A as a separate line item. If the consortium partner's F&A is not part of the requester's MTDC on the check list, but is listed separately, the requester could not accurately calculate their own F&A. Regards, Manuela Manuela Dokie Senior Research Administrator Office of Sponsored Programs University of Nevada Las Vegas Phone: (702) 895-1357 Fax: (702) 895-0986 Robert Miller <xxxxxx@CDREWU.EDU> Sent by: Research Administration List <xxxxxx@HRINET.ORG> 08/18/2005 10:39 AM Please respond to Research Administration Discussion List To: xxxxxx@HRINET.ORG cc: Subject: [RESADM-L] Checklist / F&A costs Master-budgeteers... One of my PI's seems to think that when completing the checklist (non competing continuation) you must separately list the F&A of the consortium contract (on the check list). I disagree, the instructions does not state so as the direct costs of the primary encompasses the F&A of the consortium contract. Your input would help. Thanks Robert Gregory Miller Charles R. Drew University of Medicine and Science Div. of Endocrinology, Metabolism and Molecular Science Administrative Director/Research Administrator xxxxxx@cdrewu.edu Office: 323.563.5961 Fax: 323.563.5966 Notice of Confidentiality This message contains information that may be confidential or privileged. It is intended for the exclusive use of the addressee or any person entitled to receive it. If you received this message in error, please inform the author as soon as possible, do not disclose its contents and delete it from your system ====================================================================== Instructions on how to use the RESADM-L Mailing List, including subscription information and a web-searchable archive, are available via our web site at http://www.hrinet.org (click on "Listserv Lists") ====================================================================== ====================================================================== Instructions on how to use the RESADM-L Mailing List, including subscription information and a web-searchable archive, are available via our web site at http://www.hrinet.org (click on "Listserv Lists") ====================================================================== ====================================================================== Instructions on how to use the RESADM-L Mailing List, including subscription information and a web-searchable archive, are available via our web site at http://www.hrinet.org (click on "Listserv Lists") ======================================================================